Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01183325
Other study ID # 2009/291
Secondary ID
Status Completed
Phase N/A
First received August 12, 2010
Last updated December 4, 2014
Start date September 2009
Est. completion date September 2013

Study information

Verified date December 2014
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Interventional

Clinical Trial Summary

For small (2-3cm) ventral and umbilical hernias the discussion for primary suture repair or the use of mesh continues.

About 5 years ago the Ventralex patch was introduced, which combines a layer of PTFE mesh with a small polypropylene mesh and includes a circular memory ring. Despite the elegance of using this patch, recent experience showed several drawbacks both in design and efficacy (3).

With the recent development of the Proceed Ventral Patch (PVP), new elements have been introduced to overcome some of these issues.

The aim of this study is to evaluate the efficacy of clinical placement of the PVP in the intra-abdominal position in the treatment of small ventral hernias.


Recruitment information / eligibility

Status Completed
Enrollment 160
Est. completion date September 2013
Est. primary completion date April 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patient

- Written informed consent

- Umbilical, primary ventral hernias smaller than 3cm diameter

Exclusion Criteria:

- Hernias larger than 3cm

- Recurrence

- Children

- Emergency cases

- Incisional hernias

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Device:
Proceed Ventral Patch placement
Placement of a Proceed Ventral Patch for umbilical and small ventral hernias less than 3cm diameter with and without laparoscopic control

Locations

Country Name City State
Belgium Imelda Hospital Bonheiden
Belgium University Hospital Ghent Ghent

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Ghent Johnson & Johnson

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of adequately placed patches At T 0 days No
Secondary Perioperative morbidity rate Within 30 days No
Secondary Pre- and postoperative pain At T 0 day, T 30 days and T 1 year No
Secondary Number of patients needed a repositioning of the patch At T 0 days No
Secondary Reasons for inadequate positioning At T 0 days No
Secondary Number of repositioning necessary At T 0 days No
Secondary Complication ratio At 1 year No
Secondary Recurrence rate at 1 year At 1 year No
See also
  Status Clinical Trial Phase
Completed NCT01673568 - Abdominal Binder to Reduce Pain and Seroma Formation N/A
Completed NCT01962480 - The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain N/A
Withdrawn NCT02730936 - Antimicrobial Hernia Repair Device N/A
Completed NCT01784822 - Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair N/A